VP, Bioanalytical Development
- Expertise
- Services
- Solutions
- About Us
- Resources
Expertise
Services
Solutions
About Us
About Us- Overview
- Leadership
- Facility and Equipment
- Quality and Compliance
- Therapeutic Areas
- Why Us?
- Values
- Process
- Partners
- Careers
Business Development Associate
Sr. Scientist – Cell Based Assay
GLP Quality Assurance Manager
Sr. Scientist, ELISA Immunoassay Bioanalysis
Sr. Scientist, LC-MS/MS Bioanalysis
Associate Scientist, Central Laboratory Services
Sr. Scientist - Pharmacokinetics (PK)
Content Manager, Scientific and Regulatory Writing
Resources
Nimble Central Lab Solutions For Your GCP Clinical Trials Bioanalysis CRO Services!
- GCP Clinical Trials CRO Bioanalytical Method Development, Validation, And Sample Analysis Lab Services
- FDA Audited, Watson LIMS Enabled Facility For Clinical Bioanalysis Assessment Of Novel Drugs, Reformulations, Or Generics
- High-Value And Reliable Clinical Bioanalysis Services Experienced With LC-MS/MS, ELISA, MSD, Luminex, Or qPCR On 500+ Projects
- Full-Service Bioanalysis Provider: First-In-Human Clinical Trials CRO For NDA From Preclinical IND Testing
Regulated And Inspected By:
Contact A Scientist For Clinical CRO Services
We Will Respond Within 1 Business Day
Click below for answers to your Clinical CRO questions -
Ask Us About Your Study
Clinical Trials CRO services involve bioanalysis on first in human research studies to evaluate the safety and efficacy of drugs or formulations. Specifically, Clinical Bioanalysis studies help evaluate the pharmacokinetic properties and bioavailability of drugs, metabolites, and prodrugs as well as run bioequivalence assessments for reformulations or generics. NorthEast BioLab is a premier Clinical CRO trusted by top biotech companies steering towards approval. Over the last 20+ years, our veteran team has delivered GLP/GCP Clinical Trial CRO services on 400+ studies. We provide reliable and actionable Clinical Bioanalysis CRO services for a streamlined path to drug development.
What are Clinical Trials and associated CROs?
Clinical Trials CRO: Drug Safety and Efficacy in Humans
Clinical trials are research studies that are carried out to assess the effect of novel drugs or devices on the human body to prevent, cure, or manage various medical conditions. These trials evaluate the safety and efficacy of the medical treatment on the human body for the first time. Clinical trials are conducted in observance of strict protocols and guidelines to help gain valuable and actionable data for making informed decisions about the treatment under review.
Clinical trials are only initiated after the drug safety in animals has been clearly understood. That said, drug safety for humans is not guaranteed even as the drug toxicity in the animals has been evaluated. Therefore, clinical trials are typically initiated with a modest dosage of the drug to a small group of volunteers. Additional trials are then initiated following the results from these smaller trials.
Before the beginning of each clinical trial, a comprehensive protocol is drafted that includes the study objectives, design, scientific background, and statistical information. These protocols are the guardrails put together based on regulatory guidelines and contain at least following information –
- Study endpoints
- Length of the study
- Number of participants
- Eligibility criteria for patients or volunteers
- Drug dose and complete plan
- Clinical tests to monitor vital signs and ensure patient safety
Sponsors Love Our Bioanalytical Laboratory Services For Top Quality And Industry Leading Turnaround
Connect With Us For A Reference Call With Them!
NorthEast BioLab is a responsive, collaborative, and reliable partner
We trust NorthEast BioLab to design and execute streamlined, impactful bioanalytical projects
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism
NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.
“NorthEast BioLab goes the extra mile. We look forward to more meaningful collaborations.”
NorthEast BioLab offers a science-based, hands-on approach to the latest bioanalytical platforms
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
This study, same as all other bioanalytical studies, was completed with top quality and reporting standard with incredible responsiveness.
NorthEast BioLab’s scientists deliver high-quality data on time and within budget
Tackle Your Clinical Trials Bioanalysis With Our Veteran Team Now!
Which Clinical Bioanalysis CRO services do we offer?
Clinical Bioanalysis CRO services by NorthEast BioLab
NorthEast BioLab provides a range of clinical laboratory services from supplying the clinical kits for sample collection to pharmacokinetic, toxicokinetic, and biomarker bioanalysis, as well as long term storage of the biological samples. Our unified offering of these services enables the successful and seamless execution of your clinical trials.
Clinical Sample Collection Kits
Every sample collection kit assembled by your clinical research organization should comply with the specific requirements of the clinical trial protocol. At NorthEast BioLab we understand the advanced sampling needs of different clinical trials, and our sample kit contents are thoughtfully decided according to the following factors:
- Study type – Pharmacokinetic, Toxicokinetic, and Biomarker testing, etc.
- Study design – Number of volunteers, timepoints, duration, etc.
- Study matrices – Serum, plasma, whole blood, urine, stool, cerebral spinal fluid, tissue, etc.
- Sample /specimen volume collected
- Required stabilizing inhibitors or anticoagulants
Pharmacokinetic, Toxicokinetic, and Biomarker Bioanalysis
Our CRO services cover toxicokinetic, pharmacokinetic, and biomarker bioanalysis of samples collected during clinical trials.
- Pharmacokinetic testing of clinical trial samples by our scientists helps in assessing the effect of the human body on the drug under evaluation. This process analyses the absorption, distribution, metabolism, and excretion along with bioavailability of the drug compound.
- Toxicokinetic studies help understand the relationship between external drug exposure with target organ dosimetry as well as adverse effects. Generally, drug absorption, distribution, metabolism, and excretion at varying dose is closely monitored in these studies as well.
- Biomarker testing helps in evaluating the absolute and relative efficacy and safety profile of select drug candidates.
Long-term Clinical Sample Storage
Biological samples collected during a clinical trial must be appropriately stored and tracked for a full chain of custody until disposal. Regulatory agencies pay utmost attention to this to ensure that samples are stored in proper conditions to maintain the stability of the drug as this can impact the evaluation of the drug and provide erroneous results. At NorthEast BioLab, we can store and monitor biological samples under various conditions which range from 4C, -20C, -80C, and under liquid nitrogen. All our freezers are tracked 24/7 with multiple backup generators for an emergency.
Registered And Inspected By Various Regulatory Agencies
Don’t Wait, Start Your Clinical Trials Bioanalysis Service Today!
Why choose us for your Clinical Trials CRO Services?
Outstanding Clinical Trials CRO to gain your Competitive Edge
NorthEast BioLab has 20+ years experience in helping sponsors accelerate their clinical trial timeline. We offer clinical laboratory services in strict compliance with regulatory guidelines to positively impact the intended purpose of your clinical trials. We are a clinical research organization that can manage and monitor your complicated clinical studies seamlessly, utilizing our bioanalysis and project management expertise, skilled scientists, technicians, and managers, as well as latest equipment and state-of-the facility. Thus, you can rely on NorthEast BioLab CRO services to advance your drugs with a shorter time to market, accurate efficacy and safety profile, and lower operational costs. Our team of expert scientists is eagerly looking to speak with you, whether you ended up here through a kind reference from one of our existing clients or through a regular Google search of clinical research organizations near me.
Drug Discovery and Development Process
How long do you think it takes for a new drug to get approved in the US? About 12-15 years, that’s roughly 1/3rd duration of the entire professional career for any of us. Next, how much investment do you think is required to bring a new drug…
What are the different phases in Clinical CRO services?
Clinical CRO Services Across Phase I-IV and beyond
Clinical trials for drug development span over four stages. These stages or clinical trial phases follow the advancement of a drug product through regulatory approval.
Phase I
Phase I of the clinical trial is executed with a small group – around 20-100 healthy individuals. Generally, the side-effects in this stage are minor as the human volunteers receive a low dose of the drug compound. Here, the drug intake is increased gradually to realize an optimal dosage while taking note of the side-effects. The study is designed to determine the treatment effects including the drug absorption, distribution, metabolism, and excretion.
Phase II
In this stage, the medical treatment is assessed on around 100 to 300 diseased patients for a few months to a couple of years. Most phase II studies are randomized and blinded, where the “control” group receives a standard treatment or placebo and the other set of patients receives the new drug. The aim of Phase II is to gather information about the relative safety and effectiveness of the drug.
Phase III
Phase III is an extension of phase II with a larger population (300 -3,000 or more individuals) to establish a thorough understanding of drug efficacy and safety, including the entire range of possible adverse reactions. Based on the success in this stage, the drug product is submitted to the FDA or other regulatory agencies for approval.
Phase IV
In Phase IV, the long-term effects of new drugs and treatments are identified and evaluated over an extended period. This phase is possible only once a new drug has the FDA approval and doctors can recommend it to patients.
